Thomas Catinazzo - Mar 30, 2021 Form 4/A - Amendment Insider Report for Relay Therapeutics, Inc. (RLAY)

Signature
/s/ Brian Adams, as Attorney-in-Fact
Stock symbol
RLAY
Transactions as of
Mar 30, 2021
Transactions value $
-$694,800
Form type
4/A - Amendment
Date filed
6/9/2021, 08:33 PM
Date Of Original Report
Apr 1, 2021
Next filing
Jun 9, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RLAY Common Stock Options Exercise $92.7K +22.5K +141.78% $4.12 38.4K Mar 30, 2021 Direct F1
transaction RLAY Common Stock Sale -$788K -22.5K -58.64% $35.00 15.9K Mar 30, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RLAY Stock Option (Right to Buy) Options Exercise $0 -22.5K -17.37% $0.00 107K Mar 30, 2021 Common Stock 22.5K $4.12 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 17, 2020.
F2 Twenty-five percent (25%) of the shares underlying this option vested on April 9, 2019 and the remainder shall vest in equal quarterly installments over the remaining thirty-six (36) months, subject to the reporting person's continued employment through each vesting date.

Remarks:

The Form 4 filed on April 1, 2020 by the reporting person inadvertently understated the number of shares beneficially owned following the reported transactions by 15,870 shares in Column 5 of Table I.